In vivo evaluation of non-competitive 89Zr-labeled nanobody tracers targeting

Melinda Badenhorst (AUMC)
Presentation: In vivo evaluation of non-competitive ⁸⁹Zr-labeled nanobody tracers targeting

Focusing on the clinical application of immune imaging, Melinda Badenhorst presented her work on how molecular imaging techniques can support treatment monitoring and patient stratification. Her research explores how imaging data can provide valuable insights into therapy response, particularly in oncology and inflammatory diseases. By integrating imaging into clinical workflows, this work contributes to more informed decision-making and supports the development of personalised treatment strategies. These advancements highlight the growing role of imaging in improving both clinical outcomes and efficiency in healthcare.